# Non-interventional, Retrospective Cohort Study to Explore Antidepressant Treatment in Korea

> **NCT04446039** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 370212 (actual)

## Conditions studied

- Major Depression

## Interventions

- **DRUG:** Escitalopram
- **DRUG:** Paroxetine
- **DRUG:** Fluoxetine
- **DRUG:** Mirtazapine
- **DRUG:** Duloxetine
- **DRUG:** Sertraline
- **DRUG:** Venlafaxine
- **DRUG:** Tianeptine
- **DRUG:** Vortioxetine
- **DRUG:** Desvenlafaxine
- **DRUG:** Bupropion

## Key facts

- **NCT ID:** NCT04446039
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-04
- **Primary completion:** 2022-11-03
- **Final completion:** 2022-11-03
- **Target enrollment:** 370212 (ACTUAL)
- **Last updated:** 2024-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04446039

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04446039, "Non-interventional, Retrospective Cohort Study to Explore Antidepressant Treatment in Korea". Retrieved via MORVS 2026-09-29 from https://api.morvs.ai/clinical/NCT04446039. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*